Dr. Ampudia-Blasco has a degree in Medicine and Surgery from the University of Valencia (1987, Extraordinary Prize), Doctor in Medicine from the Autonomous University of Barcelona (1994, Apto Cum Laude, Extraordinary Prize), Head of Section of the Service of Endocrinology and Nutrition of the Clinic University Hospital of Valencia since September 2018, Associate Professor of the Department of Medicine since 1999 and researcher at CIDERDEM. He is the author of numerous originals, book chapters, and co-editor of several monographs and books. Dr. Ampudia-Blasco has received several scholarships and awards, highlighting his stay as a researcher at the Abteilung für Stoffwechsel und Ernährung, MNR Klinik und Poliklinik der Heinrich-Heine Universität, Düsseldorf (Prof. Michael Berger, 1992-1994). Between 2005-2010 he has been the Director of ‘Avances en Diabetología’, the official journal of the Spanish Diabetes Society, and is currently a reviewer of, Endocrinology, Diabetes and Nutrition, Spanish Clinical Journal, Diabetes Care, Diabetes, Obesity and Metabolism, Diabetes Research and Clinical Practice, Diabetic Medicine, Diabetologia, Diabetes Technology & Therapeutics, Metabolism, Journal of Diabetes and Its Complications, Journal of Diabetes Science and Technology, Diabetes Metabolism Research and Reviews, Annals of Medicine, Clinical Endocrinology, and The International Journal of Clinical Practice.

Nicholas B. Argento, MD FACE is a senior clinical endocrinologist at the Maryland Endocrine and Diabetes Center in Columbia, Maryland, where he serves as the Diabetes Technology Director and actively manages more than 500 patients on CGM, many for more than a decade. His practice emphasizes the implementation of advanced diabetes technology and other treatments to improve the lives of those with diabetes. His experience is enriched by living with T1D since 1968. He co-authored multiple chapters in the American Diabetes Association 2013 book, “Putting Your Patient on the Pump,” and is co-author of the 3rd edition, currently in preparation. He was primary investigator for 3 published retrospective studies on clinical aspects of CGM use, was first author or contributor to multiple commentaries on personal CGM use and was first author of a T1D Exchange publication on the adverse impact of Medicare pump policies on patient care. He has presented on clinical aspects of CGM and diabetes technology at ADA, EASD, AACE, and Diabetes Technology Society scientific sessions, and spoken to regional, national and international audiences on CGM and insulin pump use.